CFO Tobin Schilke sold $107K of Revance Therapeutics, Inc.

Sold$107,234

$33.50Price

3,201Shares

−6%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Wed, Mar 1. Filed Thu, Mar 2, 4:25 PM ET, after the close. Not investment advice.